THE PROTECT STUDY: EFFECT OF 35 MONTH EVEROLIMUS MONOTHERAPY VS. CALCINEURIN INHIBITOR-BASED THERAPY ON EFFICACY AND RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS

被引：0
|
作者：
Schlitt, H. [1 ]
Kaiser, G. [2 ]
Richter, N. [3 ]
Heyne, N. [4 ]
Rauchfuss, F. [5 ]
Pascher, A. [6 ]
Schemmer, P. [7 ]
Fischer, L. [8 ]
Paulus, E. [9 ]
Mertens, M. [9 ]
Sterneck, M. [8 ]
机构：
[1] Univ Hosp Regensburg, Dept Surg, Regensburg, Germany
[2] Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany
[3] Hannover Med Sch MHH, Clin Gen Abdominal & Transplant Surg, Hannover, Germany
[4] Univ Tubingen Hosp, Dept Gen Visceral & Transplant Surg, Tubingen, Germany
[5] Jena Univ Hosp, Dept Gen Abdominal & Vasc Surg, Jena, Germany
[6] Charite Univ Med Ctr Berlin, Clin Gen Abdominal & Transplant Surg, Berlin, Germany
[7] Univ Heidelberg Hosp, Dept Gen Visceral & Transplant Surg, Heidelberg, Germany
[8] Univ Med Ctr Eppendorf, Dept Gen Surg & Transplantat, Hamburg, Germany
[9] Novartis Pharma GmbH, Nurnberg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
下载
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [21] Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 3 Year Data of the APOLLO Trial
    Rath, T.
    Budde, K.
    Sommerer, C.
    Haller, H.
    Suwelack, B.
    May, C.
    Paulus, E. -M
    Witzke, O.
    Reinke, P.
    TRANSPLANTATION, 2012, 94 (10) : 994 - 994
  • [22] TWO YEAR DATA OF THE APOLLO TRIAL: RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS
    Reinke, P.
    Haller, H.
    Rath, T.
    Arns, W.
    Paulus, E. -M.
    Scheidl, S.
    Witzke, O.
    Sommerer, C.
    Budde, K.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 50 - 50
  • [23] Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study
    Ganschow, Rainer
    Ericzon, Bo-Goran
    Dhawan, Anil
    Sharif, Khalid
    Martzloff, El-Djouher
    Rauer, Barbara
    Ng, Jennifer
    Lopez, Patricia
    PEDIATRIC TRANSPLANTATION, 2017, 21 (07)
  • [24] THE PROTECT STUDY: SUSTAINED SUPERIOR RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS AFTER 35 MONTHS
    Sterneck, Martina
    Kaiser, Gernaud
    Richter, Nicolas
    Heyne, Nils
    Rauchfuss, Falk
    Schemmer, Peter
    Fischer, Lutz
    Paulus, Eva-Maria
    Mertens, Michael
    Schlitt, Hans-Juergen
    TRANSPLANT INTERNATIONAL, 2013, 26 : 146 - 146
  • [25] THE TRANSFORM STUDY: 12-MONTH EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITOR IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Pascual, Julio
    Berger, Stefan
    Witzke, Oliver
    Chadban, Steve
    Oppenheimer, Federico
    Oberbauer, Rainer
    Watarai, Yoshihiko
    Legendre, Christophe
    Luo, Wen-Lin
    Marti, Anamaria
    Bernhardt, Peter
    Tedesco, Helio
    TRANSPLANT INTERNATIONAL, 2017, 30 : 159 - 159
  • [26] OUTCOME ON RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS: 5 YEAR DATA OF THE APOLLO TRIAL
    Rath, T.
    Sommerer, C.
    Suwelack, B.
    Arns, W.
    Haller, H.
    Reinke, P.
    Budde, K.
    Baeumer, D.
    Porstner, M.
    Witzke, O.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 50 - 50
  • [27] Outcome on Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 4 Year Data of the APOLLO Trial
    Budde, K.
    Sommerer, C.
    Reinke, P.
    Haller, H.
    Arns, W.
    Witzke, O.
    Suwelack, B.
    May, C.
    Baeumer, D.
    Paulus, E.
    Rath, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 311 - 312
  • [28] Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 2 Year Data of the APOLLO Trial.
    Budde, K.
    Sommerer, C.
    Haller, H.
    Arns, W.
    Kramer, S.
    Vogel, E. -M.
    Witzke, O.
    Reinke, P.
    Rath, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 411 - 411
  • [29] Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 3 Year Data of the APOLLO Trial.
    Budde, K.
    Sommerer, C.
    Haller, H.
    Suwelack, B.
    May, C.
    Paulus, E. -M.
    Witzke, O.
    Reinke, P.
    Rath, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 298 - 298
  • [30] 4 YEAR DATA OF THE APOLLO TRIAL: OUTCOME ON RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS
    Sommerer, C.
    Rath, T.
    Haller, H.
    Arns, W.
    Suwelack, B.
    Reinke, P.
    May, C.
    Baeumer, D.
    Paulus, E. -M.
    Witzke, O.
    Budde, K.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 21 - 21
12345